Select Page

Our Keratoconus Research

Clinical research

We focus on better investigating the frequency of keratoconus worldwide. Keratoconus has been referred to as a “rare disease” for more than 30 years because it appears to occur only in a human of 2,000. In a first large-scale pilot study in the Arabic-speaking world, we have now shown that in some areas of the world the disease is up to 100 times more common than previously thought. More information can be found here .

Basic research

As a co-developer of the cross-linking of the cornea, we align our entire basic research to answer open questions from the clinic around the topic of cross-linking. For example, we were the first to cross-link ectasia after LASIK and PRK in 2007 , as well as the first to treat very thin corneas with hypo-osmolar solution in 2009. We are currently focusing on developing treatment techniques that will enable the treatment of extremely thin corneas (down to 220 μm corneal thickness).

All topics are dealt with by our teams in our two research laboratories at the Universities of Zurich and USC Los Angeles.

Our publications on keratoconus and cross-linking

What effect does CXL have after 10 years?

What effect does CXL have after 10 years? ...

Moving the Corneal Cross-Linking Procedure from the OR to the Slit Lamp

A typical corneal cross-linking (CXL) procedure is performed ...

CXL for ultra-thin corneas: the sub400 protocol webinar

the sub400 protocol individualized CXL
On Tuesday, April 28th, 2020, Prof. Farhad Hafezi ...

Knowledge Transfer from Across The Pond

Prof. Farhad Hafezi speaks at the Bascom Palmer ...

Making CXL at the slit lamp reality

This month, Brazil's top Ophthalmology magazine, Oftalmologica Em Foco, features ELZA’s Prof. Hafezi and Dr. Torres-Netto exploring the story of how CXL at the slit lamp is becoming a reality.
This month, Brazil's top Ophthalmology magazine, Oftalmologica Em ...

Democratizing Corneal Cross-Linking

This month, Brazil's top Ophthalmology magazine, Oftalmologica Em ...

CXL breakthrough – thin keratoconus corneas can be treated with “sub400”

The ELZA Institute's Prof. Hafezi has revealed the ...
Menu

The ELZA Institute

EN
DE |